What is the share price of Tarsons Products Ltd (TARSONS) today?
The share price of TARSONS as on 30th May 2025 is ₹374. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Tarsons Products Ltd (TARSONS) share?
The past returns of Tarsons Products Ltd (TARSONS) share are- Past 1 week: 2.78%
- Past 1 month: 5.83%
- Past 3 months: 29.97%
- Past 6 months: -5.72%
- Past 1 year: -5.56%
- Past 3 years: -42.66%
- Past 5 years: -51.65%
What are the peers or stocks similar to Tarsons Products Ltd (TARSONS)?
The peers or stocks similar to Tarsons Products Ltd (TARSONS) include:What is the market cap of Tarsons Products Ltd (TARSONS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Tarsons Products Ltd (TARSONS) is ₹2045.25 Cr as of 30th May 2025.What is the 52 week high and low of Tarsons Products Ltd (TARSONS) share?
The 52-week high of Tarsons Products Ltd (TARSONS) is ₹543.90 and the 52-week low is ₹280.What is the PE and PB ratio of Tarsons Products Ltd (TARSONS) stock?
The P/E (price-to-earnings) ratio of Tarsons Products Ltd (TARSONS) is 68.72. The P/B (price-to-book) ratio is 3.34.Which sector does Tarsons Products Ltd (TARSONS) belong to?
Tarsons Products Ltd (TARSONS) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Tarsons Products Ltd (TARSONS) shares?
You can directly buy Tarsons Products Ltd (TARSONS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Tarsons Products Ltd
TARSONS Share Price
374.002.71% (-10.40)
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TARSONS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TARSONS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 68.75 | 3.34 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.46 | 6.50 | 0.85% |
TARSONS Analyst Ratings & Forecast
Detailed Forecast 80%
Analysts have suggested that investors can buy this stock
from 5 analysts
Price Upside
Earnings Growth
Rev. Growth
TARSONS Company Profile
Tarsons Products Limited is engaged in the designing, development, manufacturing of a range of labware products which helps scientific discovery and healthcare
Investor Presentation
View olderTARSONS Similar Stocks (Peers)
Compare with peersPE Ratio
51.59
1Y Return
20.51%
Buy Reco %
25.00
POLYMED
PE Ratio
68.38
1Y Return
24.58%
Buy Reco %
60.00
LAXMIDENTL
PE Ratio
64.57
1Y Return
30.98%
Buy Reco %
100.00
BOROSCI
PE Ratio
46.22
1Y Return
11.08%
Buy Reco %
—
PREVEST
PE Ratio
32.23
1Y Return
28.40%
Buy Reco %
—
TARSONS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
TARSONS Stock Summary · February 2025
The company has demonstrated robust revenue growth, achieving a 23.3% increase year-over-year, driven by strong domestic and international demand, particularly in lab consumables. However, this growth is tempered by challenges such as declining profit margins due to high depreciation costs from the Panchla plant and competitive pressures in the market. Strategic investments in automation and new product lines, especially in cell culture, are expected to enhance operational efficiencies and capture a larger market share. While management anticipates improved EBITDA margins as production ramps up, the path to profitability remains cautious, with a focus on stabilizing costs and aligning operational capabilities with rising demand. Overall, the outlook remains optimistic, supported by a commitment to quality and customer engagement.
Key Points on Tarsons Stock
TARSONS Stock Growth Drivers
8Strong Financial Performance
The company reported standalone revenues of INR 76.2 crores for Q3 FY '25, marking a
Expansion of Product Portfolio
The company has introduced a new cell culture and bioprocess product portfolio, which is expected
TARSONS Stock Challenges
6Declining Profitability Metrics
The company's profit after tax (PAT) margin has significantly decreased from approximately 20% pre-COVID to
Increased Costs and Lower Margins
The EBITDA margin for the quarter has decreased to 31%, influenced by increased costs that
TARSONS Forecasts
TARSONS Forecast
Price
Revenue
Earnings
TARSONS Share Price Forecast
2025
Current
₹395.70
Baseline
Forecast for May 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹395.70
Baseline
Forecast for May 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
TARSONS Company Revenue Forecast
2025
Current
₹408.37
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹408.37
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
TARSONS Stock EPS (Earnings Per Share) Forecast
2025
Current
₹5.60
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹5.60
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
TARSONS
Income
Balance Sheet
Cash Flow
Annual Normal View
TARSONS Income Statement
Annual Normal View
| Financial Year | FY 2024 | FY 2025 | TTM | |||
|---|---|---|---|---|---|---|
| Total Revenue | 307.87 | 408.37 | 408.37 | |||
Raw Materials | 79.27 | 281.69 | 281.69 | |||
| Power & Fuel Cost | 10.88 | |||||
| Employee Cost | 44.27 | |||||
| Selling & Administrative Expenses | 26.44 | |||||
| Operating & Other expenses | 35.69 | |||||
EBITDA | 111.32 | 126.68 | 126.68 | |||
| Depreciation/Amortization | 40.40 | 62.50 | 62.50 | |||
| PBIT | 70.92 | 64.18 | 64.18 | |||
| Interest & Other Items | 10.15 | 19.39 | 19.39 | |||
| PBT | 60.77 | 44.79 | 44.79 | |||
| Taxes & Other Items | 18.13 | 15.03 | 15.04 | |||
| Net Income | 42.64 | 29.76 | 29.75 | |||
| EPS | 8.01 | 5.60 | 5.59 | |||
| DPS | 2.00 | 0.00 | 2.00 | |||
| Payout ratio | 0.25 | 0.00 | 0.36 |
TARSONS Company Updates
FY 2025
Investor Presentation
May 28PDF
Feb 14PDF
Nov 7PDF
TARSONS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Tarsons Products Ltd | 68.72 | 3.34 | — |
| Inventurus Knowledge Solutions Ltd | 51.59 | 21.66 | — |
| Poly Medicure Ltd | 68.38 | 15.75 | 0.15% |
| Laxmi Dental Ltd | 64.57 | 46.04 | — |
TARSONS Stock Price Comparison
Compare TARSONS with any stock or ETFCompare TARSONS with any stock or ETF
TARSONS
TARSONS Shareholdings
TARSONS Promoter Holdings Trend
TARSONS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has increased by 2.01%
TARSONS Shareholding Pattern
TARSONS Shareholding History
Foreign Institutions
Mutual Funds Invested in TARSONS
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 1 Mutual Funds holding Tarsons Products Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0004% | Percentage of the fund’s portfolio invested in the stock 0.04% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 95/109 (-2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing TARSONS stock
Looks like this stock is not in any smallcase yet.
TARSONS Events
TARSONS Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TARSONS Upcoming Dividends
No upcoming dividends are available
TARSONS Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2024
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 20, 2024
TARSONS Stock News & Opinions
Articles & Videos
Earnings
Tarsons Products consolidated net profit declines 1.16% in the March 2025 quarter
Net profit of Tarsons Products declined 1.16% to Rs 10.20 crore in the quarter ended March 2025 as against Rs 10.32 crore during the previous quarter ended March 2024. Sales rose 6.59% to Rs 112.69 crore in the quarter ended March 2025 as against Rs 105.72 crore during the previous quarter ended March 2024. For the full year,net profit declined 30.18% to Rs 29.77 crore in the year ended March 2025 as against Rs 42.64 crore during the previous year ended March 2024. Sales rose 32.40% to Rs 392.41 crore in the year ended March 2025 as against Rs 296.39 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales112.69105.72 7 392.41296.39 32 OPM %32.8528.61 -28.2233.68 - PBDT35.6029.37 21 107.30101.17 6 PBT15.5717.04 -9 44.8060.77 -26 NP10.2010.32 -1 29.7742.64 -30 Powered by Capital Market - Live
1 day agoCapital Market - Live
Corporate
Tarsons Products to table results
Tarsons Products will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
6 days agoCapital Market - Live
Earnings
Tarsons Products standalone net profit declines 24.43% in the December 2024 quarter
Net profit of Tarsons Products declined 24.43% to Rs 7.61 crore in the quarter ended December 2024 as against Rs 10.07 crore during the previous quarter ended December 2023. Sales rose 23.26% to Rs 76.16 crore in the quarter ended December 2024 as against Rs 61.79 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales76.1661.79 23 OPM %36.6637.03 - PBDT25.9123.75 9 PBT10.3013.69 -25 NP7.6110.07 -24 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Tarsons Products schedules board meeting
Tarsons Products will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Tarsons Products standalone net profit rises 1.02% in the September 2024 quarter
Net profit of Tarsons Products rose 1.02% to Rs 12.93 crore in the quarter ended September 2024 as against Rs 12.80 crore during the previous quarter ended September 2023. Sales rose 20.81% to Rs 80.12 crore in the quarter ended September 2024 as against Rs 66.32 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales80.1266.32 21 OPM %29.3438.27 - PBDT29.4827.03 9 PBT17.5217.32 1 NP12.9312.80 1 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Tarsons Products declare Quarterly Result
Tarsons Products will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Tarsons Products to conduct AGM
Tarsons Products announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Tarsons Products standalone net profit declines 32.71% in the June 2024 quarter
Net profit of Tarsons Products declined 32.71% to Rs 6.46 crore in the quarter ended June 2024 as against Rs 9.60 crore during the previous quarter ended June 2023. Sales rose 3.64% to Rs 64.85 crore in the quarter ended June 2024 as against Rs 62.57 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales64.8562.57 4 OPM %26.2334.04 - PBDT17.6721.15 -16 PBT8.7112.85 -32 NP6.469.60 -33 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Tarsons Products to convene board meeting
Tarsons Products will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Buy Tarsons Products Ltd; target of Rs 770: LKP Research
1 year agoMoneycontrol
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant